Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Galena Biopharma Inc    GALE   US3632561086

SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 

Galena Biopharma Inc : Stocks Reports For: (NASDAQ: GALE), (NYSE: CIM)

03/12/2013 | 12:50pm US/Eastern
Recommend:
0

New York (March 12th, 2013) - Galena Biopharma Inc. (NASDAQ: GALE) stock is at $2.083, up 2.61 percent from its previous close of $2.03. The stock shows bullish trend as it made the up move with trading volume of 1.696 million shares, in contrast to the average daily trading volume of 1.909 million shares. Its bullish trend is further confirmed by its MACD chart and the stock is also trading higher than its 6 days SMA of $2.06. The stock may go as high as $2.15 in its coming trading sessions.

Galena Biopharma stock has its first support level at $2.02. The company deals in bio therapies.

Find out if GALE could maintain its momentum by getting the free and full trend analysis report here:

http://www.wallstreetscoop.net/market-scan/?symbol=GALE


Chimera Investment Corporation (NYSE: CIM) opened at $3.17 and oscillated in the range of $3.17 and $3.24 in the latest trading session. It is at $3.18, down 0.22 percent from its previous close of $3.19. Despite the down move, Chimera Investment shows bullish trend and the stock’s first resistance level is at $3.25. Upon breaching this level, the stock may touch $3.40. On the downside, it may slip to $3.06. The stock has traded 4.651 million shares so far.

Chimera Investment is a real estate investment trust and deals in residential mortgage loans. The company is based out of New York.

Find out where CIM could be headed by getting the free and full trend analysis report here:

http://www.wallstreetscoop.net/market-scan/?symbol=CIM

About Us:

WallStreetScoop.net issues momentum alerts on stocks that can provide gains to day traders and short-term investors. WallStreetScoop.net provides members with timely information and exclusive alerts on under-valued stocks in the United States with the potential to deliver short-term gains.

WallStreetScoop.net monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities. Through a vast network of IR professionals WallStreetScoop.net is often in the know of several large investor awareness campaigns being deployed.

Timing is everything when trading small cap stocks. Gain an Edge by joining the WallStreetScoop.net newsletter and receiving alerts from a Pro-Active team of researchers. Wall Street Scoop believes traders should have a chance at successfully trading Small stocks and invites traders and investors to be part of the free membership.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.WallStreetScoop.net

Disclosure: WallStreetScoop.net is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit WallStreetScoop.Net website, for complete risks and disclosures.

Investor Alley, its employees, officers, directors, shareholders and affiliates, hold no positions in the above-mentioned stocks.

For full disclaimer visit: www.wallstreetscoop.net/disclaimer/

Contact Info:

Thomas Greene
Wall Street Scoop
info@wallstreetscoop.net
347-905-5009


© Accesswire 2013
Recommend :
0
React to this article
Latest news on GALENA BIOPHARMA INC
7d ago GALENA BIOPHARMA : Lieff Cabraser Reminds Galena Biopharma, Inc. Investors of Up..
04/10 GALENA BIOPHARMA : SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors o..
04/09 GALENA BIOPHARMA : SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have..
04/03 GALENA BIOPHARMA : INVESTOR ALERT: Glancy Binkow & Goldberg LLP Reminds Investor..
04/03 GALENA BIOPHARMA : to Present at the 13th Annual Needham Healthcare Conference
03/31 GALENA BIOPHARMA : Hagens Berman Reminds Galena Biopharma, Inc. Investors of May..
03/28 GALENA BIOPHARMA : Cohen Milstein Sellers & Toll PLLC : Announces the Investigat..
03/26 GALENA BIOPHARMA : The Shuman Law Firm Investigates Galena Biopharma, Inc.
03/26 GALENA BIOPHARMA : Hagens Berman Investigating Galena Biopharma and CytRx Corpor..
03/21 GALENA BIOPHARMA : Lieff Cabraser Announces Class Action Litigation Against Gale..
Advertisement
Chart
Duration : Period :
Galena Biopharma Inc Technical Analysis Chart | GALE | US3632561086 | 4-Traders
Income Statement Evolution
Galena Biopharma Inc : Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF